About Cytogen Pharma
Cytogen Pharma was a Healthcare company based in Delhi (India). Manufacturer of oncology generics products. It operates on a Traditional Pharmaceuticals model. Its chief executive, as recorded, is S.M. Behl. Its Indian entity Cytogen Pharmaceuticals (India) Private Limited reported revenue of ₹14.2 Lakh. The company is recorded as dissolved. Cytogen Pharma offers products and services including Cytogen Pharma Platform. Its focus areas include Injectables, Companies, Traditional Pharmaceuticals and Oncology.
Company details
Cytogen Pharma, led by S.M. Behl as CEO MD, specializes in injectables, companies, traditional pharmaceuticals, and companies developing and commercializing generic injectable drugs. Manufacturer of oncology generics products. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
- Headquarters Delhi, India
- SectorsHealthcare
- Website cytogenpharma.com
- Legal Name Cytogen Pharmaceuticals (India) Private Limited
- Date of Incorporation 10 Dec, 2003
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹14.2 Lakh
FY 2022 · -16% YoY
- Net Profit₹1.7 Lakh
FY 2022 · 12% margin
- EBITDA₹1.7 Lakh
FY 2022 · 12% margin
Associated legal entities of Cytogen Pharma
Cytogen Pharma operates through Cytogen Pharmaceuticals (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cytogen Pharmaceuticals (India) Private Limited CIN U24239DL2003PTC123455 | Active | 10 Dec 2003 | New Delhi, Delhi | ₹0.1 Cr | 3 | View details |
Products & Services of Cytogen Pharma
Cytogen Pharma offers a comprehensive portfolio of products and services, including Cytogen Pharma Platform.
Manufacturer of oncology generics products
Board of directors of Cytogen Pharmaceuticals (India) Private Limited (Cytogen Pharma)
Cytogen Pharmaceuticals (India) Private Limited is the primary company behind Cytogen Pharma. The board of Cytogen Pharmaceuticals (India) Private Limited currently have 3 directors; the longest-serving is Venkatasatyasiva Ramakrishnaraju Bhupathiraju, appointed in 2020. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkatasatyasiva Ramakrishnaraju Bhupathiraju DIN 08926148 | Director | 26 Oct 2020 | 6 yrs | Cytogen Pharmaceuticals (India) Private Limited |
| Jhansirani Nadimpalli DIN 08477586 | Director | 26 Oct 2020 | 6 yrs | Cytogen Pharmaceuticals (India) Private Limited |
| Jayapal Garapati DIN 05327305 | Whole-time director | 12 Nov 2020 | 5 yrs 11 mo | Cytogen Pharmaceuticals (India) Private Limited |
People of Cytogen Pharma
1 people are tracked at Cytogen Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
S.M. Behl | CEO & MD | Leadership |
Complete people profiles for Cytogen Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cytogen Pharma
Figures of Cytogen Pharmaceuticals (India) Private Limited, the primary company behind Cytogen Pharma, for FY 2022. Revenue was ₹14.2 Lakh (-16% year on year). Net profit was ₹1.7 Lakh (12% margin). EBITDA was ₹1.7 Lakh (12% margin). Revenue has grown at a compounded annual rate of -44% over three years and -33% over five years.
- ₹14.2 LakhRevenue · FY 2022 · -16% YoY
- ₹1.7 LakhNet profit · 12% margin
- ₹1.7 LakhEBITDA · 12% margin
- ₹16 LakhPaid-up capital
- -44%Revenue CAGR, 3 years
- -33%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cytogen Pharmaceuticals (India) Private Limited are on its company page.
Detailed financial statements for Cytogen Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cytogen Pharma
Cytogen Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
S.M. Behl is the CEO of Cytogen Pharma, as recorded in our data.
The primary company behind Cytogen Pharma, Cytogen Pharmaceuticals (India) Private Limited, reported revenue of ₹14.2 Lakh for FY 2022, down 16% year on year.
Cytogen Pharma, led by S.M. Behl as CEO MD, specializes in injectables, companies, traditional pharmaceuticals, and companies developing and commercializing generic injectable drugs. Manufacturer of oncology generics products. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Cytogen Pharma offers Cytogen Pharma Platform.
Cytogen Pharma operates through Cytogen Pharmaceuticals (India) Private Limited.
The legal entities of Cytogen Pharma currently have 3 directors, including Jayapal Garapati, Venkatasatyasiva Ramakrishnaraju Bhupathiraju, Jhansirani Nadimpalli.